Simultaneous inhibition of metastasis and growth of breast cancer by co-delivery of twist shRNA and paclitaxel using pluronic P85-PEI/TPGS complex nanoparticles.

[1]  Yaping Li,et al.  Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer. , 2012, Biomaterials.

[2]  P. Chu,et al.  Synergistic treatment of ovarian cancer by co-delivery of survivin shRNA and paclitaxel via supramolecular micellar assembly. , 2012, Biomaterials.

[3]  Mingxing Wang,et al.  High efficiency and low toxicity of polyethyleneimine modified Pluronics (PEI–Pluronic) as gene delivery carriers in cell culture and dystrophic mdx mice , 2012 .

[4]  T. Park,et al.  A duplex oligodeoxynucleotide-dendrimer bioconjugate as a novel delivery vehicle for doxorubicin in in vivo cancer therapy. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Wei Zhang,et al.  The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models. , 2011, Biomaterials.

[6]  M. Pešić,et al.  The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines. , 2011, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[7]  Y. Bae,et al.  Prevention of metastasis in a 4T1 murine breast cancer model by doxorubicin carried by folate conjugated pH sensitive polymeric micelles. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Yaping Li,et al.  Bioreducible poly (β-amino esters)/shRNA complex nanoparticles for efficient RNA delivery. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Liandong Deng,et al.  Poly(ester anhydride)/mPEG Amphiphilic Block Co-polymer Nanoparticles as Delivery Devices for Paclitaxel , 2011, Journal of biomaterials science. Polymer edition.

[10]  Véronique Préat,et al.  To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Linyin Feng,et al.  Poly(ε-caprolactone)-Block-poly(ethyl Ethylene Phosphate) Micelles for Brain-Targeting Drug Delivery: In Vitro and In Vivo Valuation , 2010, Pharmaceutical Research.

[12]  Jun Li,et al.  Multifunctional Nanoparticles Delivering Small Interfering RNA and Doxorubicin Overcome Drug Resistance in Cancer* , 2010, The Journal of Biological Chemistry.

[13]  T. Minko,et al.  Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer. , 2008, Nanomedicine.

[14]  Alexander V Kabanov,et al.  Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[15]  M. Stack,et al.  Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion , 2007, Nature Cell Biology.

[16]  J. Massagué,et al.  Cancer Metastasis: Building a Framework , 2006, Cell.

[17]  Kanyawim Kirtikara,et al.  Sulforhodamine B colorimetric assay for cytotoxicity screening , 2006, Nature Protocols.

[18]  T. Chow,et al.  Polyethyleneimine grafted with pluronic P85 enhances Ku86 antisense delivery and the ionizing radiation treatment efficacy in vivo , 2004, Gene Therapy.

[19]  L. Brannon-Peppas,et al.  Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.

[20]  J. Massagué,et al.  Epithelial-Mesenchymal Transitions Twist in Development and Metastasis , 2004, Cell.

[21]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[22]  Gerhard Christofori,et al.  Cell adhesion and signalling by cadherins and Ig-CAMs in cancer , 2004, Nature Reviews Cancer.

[23]  W. Pitt,et al.  Drug delivery in polymeric micelles: from in vitro to in vivo. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Robert Langer,et al.  Parallel synthesis and biophysical characterization of a degradable polymer library for gene delivery. , 2003, Journal of the American Chemical Society.

[25]  D. Aggarwal,et al.  Paclitaxel and its formulations. , 2002, International journal of pharmaceutics.

[26]  Jesse T. Myers,et al.  pH-dependent regulation of lysosomal calcium in macrophages. , 2002, Journal of cell science.

[27]  S. Carotta,et al.  DNA/polyethylenimine transfection particles: Influence of ligands, polymer size, and PEGylation on internalization and gene expression , 2001, AAPS PharmSci.

[28]  F. Miller,et al.  Nontransgenic models of breast cancer. , 2000, Breast cancer research : BCR.

[29]  J. Moan,et al.  Increased binding of chlorin e6 to lipoproteins at low pH values. , 2000, The international journal of biochemistry & cell biology.

[30]  G. Badun,et al.  Interaction of tumor and normal blood cells with ethylene oxide and propylene oxide block copolymers , 1999, FEBS letters.

[31]  M. Ogris,et al.  Polylysine-based transfection systems utilizing receptor-mediated delivery. , 1998, Advanced drug delivery reviews.

[32]  L. Liotta,et al.  General mechanisms of metastasis , 1997, Cancer.

[33]  F. Miller,et al.  Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. , 1992, Cancer research.

[34]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[35]  Yun Chen,et al.  Tumor-targeted delivery of siRNA by self-assembled nanoparticles. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  J. Wolff,et al.  The mechanism of naked DNA uptake and expression. , 2005, Advances in genetics.

[37]  J. Guan,et al.  Wound-healing assay. , 2005, Methods in molecular biology.

[38]  R. Donehower,et al.  Drug therapy : paclitaxel (Taxol) , 1995 .